Shoulder pain patients in primary care--part 1: Clinical outcomes over 12 months following standardized diagnostic workup, corticosteroid injections, and community-based care.
DOI:
https://doi.org/10.2340/16501977-1860Keywords:
shoulder pain, diagnosis, follow-up studies, primary health care, corticosteroid injection.Abstract
OBJECTIVE: Measure changes in pain and disability of primary care shoulder pain patients over a 12-month period. DESIGN: A non-randomized audit with repeated measures of pain and disability at 3 weeks, 3, 6 and 12 months. PATIENTS: Of 208 patients, 161 agreed to participate with 96.9%, 98.1%, 86.3%, 83.9% follow-up at 3 weeks, at 3, 6 and 12 months, respectively. Mean age was 44 years, mean symptom duration 3.6 months. METHODS: PATIENTS were treated with protocol driven corticosteroid injection and community based care. Primary outcome measure was the Shoulder Pain and Disability index (SPADI) questionnaire. Based on the SPADI and minimal clinically important difference (MCID), outcomes were categorized into: total recovery, 90% or more improved, better, unchanged and worse. RESULTS: There was significant reduction of pain and disability at 3 weeks (p < 0.001), no change at the 3- and 6-month follow-up and a significant reduction at the 12-month follow-up (p < 0.001). Excellent outcomes were achieved by 32.9% and 45.3%, and a poor clinical outcome resulted for 32.8% and 14.9% at the 3- and 12-month follow-up, respectively. CONCLUSION: Though there was significant improvement at the 3-week and 12-month follow-up, 45% achieved an excellent outcome and a 16.7% of patients were the same or worse than baseline at 12 months.Downloads
Downloads
Published
How to Cite
Issue
Section
License
All digitalized JRM contents is available freely online. The Foundation for Rehabilitation Medicine owns the copyright for all material published until volume 40 (2008), as from volume 41 (2009) authors retain copyright to their work and as from volume 49 (2017) the journal has been published Open Access, under CC-BY-NC licences (unless otherwise specified). The CC-BY-NC licenses allow third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
From 2024, articles are published under the CC-BY licence. This license permits sharing, adapting, and using the material for any purpose, including commercial use, with the condition of providing full attribution to the original publication.